20212 ⎘
Medicinal preparations containing organic active ingredients Ketones
Iontophoretic delivery of curcumin and curcumin analogs for the treatment of Alzheimer's Disease
#1802Crystalline levosalbutamol sulphate and polymorphic forms thereof
#1803Novel Compositions for the Enhancement of the Anti-oxidant Potential of Hydrogenated Curcuminoids or Combinations Thereof
#1804Combinations of Ingredients Having Synergistic Anti-Inflammatory Effects
#1805Pharmaceutical composition
#1806Herbal compositions for the treatment of diseases of the oral cavity
#1807Drug design for tubulin inhibitors, compositions, and methods of treatment thereof
#1808Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
#1809Hops Beta-Acid Anti-Diabetic Composition
#1810Systems and processes for spray drying hydrophobic and hydrophilic components
#1811Palatable, solid oral formulations for male chemical sterilization
#1812Therapeutic formulation
#1813Androgen Receptor Related Methods for Treating Bladder Cancer
#1814Methods for Screening Interleukin-6 (IL-6) Signal Transduction Inhibitors
#1815Aminocarboxylic acid derivative and medicinal use thereof
#1816Compositions Exhibiting Inhibition Of Cyclooxygenase-2
#1817Curcuminoid Compositions Exhibiting Synergistic Inhibition Of The Expression And/Or Activity Of Cyclooxygenase-2
#1818Diagnostic Methods and Genetic Markers for Alzheimer Disease
#1819Hsp90 family protein inhibitors
#1820Novel Use of Organic Compounds
#1821Nutraceutical composition and methods for its use
#1822T type calcium channel inhibitors
#1823Method for determining physiological effects of hemoglobin
#1824Nutraceutical compositions comprising epigallocatechin gallate and raspberry ketone
#1825Compositions comprising apocynin, ginkgo and ginger and uses thereof
#1826Anti-inflammatory formulation
#1827METHOD FOR CONTROLLING NAD(P)/NAD(P)H RATIO BY OXIDOREDUCTASE
#1828Inhibitors of Akt activity
#1829Compounds and methods for the selective inhibition of ABCB1, ABCC1 and ABCG2 transporters and the treatment of cancers, especially drug resistant cancers and high throughput flow cytometry assay to detect selective inhibitors
#18303-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-1-propanone and its use in cosmetic and pharmaceutical preparations
#1831Compositions and methods using apocynin compounds and nitric oxide donors
#1832INFLAMMATORY CYTOKINE RELEASE INHIBITOR
#1833Mitigation of Inflammation-Related Injuries
#1834Pulsatile Dosing of Gossypol for Treatment of Disease
#1835BLADDER CANCER TREATMENT AND METHODS
#1836Caffeine salt complexes and methods for using the same in the prevention or treatment of cancer
#1837BUTYROPHENONES AND SIGMA-1 RECEPTOR ANTAGONISTS PROTECT AGAINST OXIDATIVE-STRESS
#1838COCKTAIL FOR MODULATION OF ALZHEIMER'S DISEASE
#1839Phospholipid complexes of curcumin having improved bioavailability
#1840Dihydroxyphenyl compounds and glucoside compounds thereof
#1841Method for preserving cells, tissues or organs using a solution comprising alkyldiamine-beta-cyclodextrin
#1842Method of lowering blood glucose and method of treating diabetes and obesity
#1843Controlled release formulations
#1844TREATMENTS FOR CONGESTIVE HEART FAILURE
#1845COMPOSITION FOR COSMETIC OR PHARMACEUTICAL-DERMATOLOGICAL USE
#1846Phenoxyalkycarboxylic acid derivatives in the treatment of ulcerative colitis
#1847Intranasally administering curcumin in a bolus of helium gas to treat alzheimers disease
#1848METHOD FOR TREATING OBESITY
#1849Xanthohumol compositions and methods of using same
#1850COMPOSITIONS AND METHODS FOR REGULATING CELLULAR PROTECTION
#1851Agent for strengthening calcium containing tissue and use thereof
#1852Cardiovascular and Brain Cell Therapy Using Intracellular Ryanodine Receptor Modulation by the Estrogen Receptor Beta
#1853PFKB3 inhibitor for the treatment of a proliferative cancer
#1854ACTIVE SUBSTANCE COMBINATION OF LICOCHALCONE A AND PHENOXYETHANOL
#1855Methods and compositions that enhance bioavailability of coenzyme-Q10
#1856Blockade of Pin1 Prevents Cytokine Production by Activated Immune Cells
#1857Compounds and compositions for reducing lipid levels
#1858PHARMACEUTICAL COMPOSITION COMPRISING CURCUMIN AND RESVERATROL AND USES THEREOF IN MEDICAL FIELD
#1859Therapeutic formulation
#1860ANTITUMOR AGENT
#1861Use of opioid receptor antagonists
#1862Peroxisome proliferator activated receptor ligand and process for producing the same
#1863Fenofibrate compositions
#1864Compositions including androgen receptor degradation (ARD) enhancers and methods of prophylactic or therapeutic treatment of skin disorders and hair loss
#1865NON-ABSORBENT ARTICLES CONTAINING ADDITIVES
#1866METHODS FOR ADDING FATTY ACIDS TO AGENTS IN AQUEOUS SOLUTION TO IMPROVE BIOAVAILABILITY
#1867Polyphenol coxib combinations and methods
#1868CURCUMIN AND CURCUMINOID INHIBITION OF ANGIOGENESIS
#1869Treatment of psychiatric disorders using entacapone, tolcapone and other COMT inhibitor or MB-COMT inhibitor drugs
#1870Antiviral compounds and methods of using thereof
#1871Ginger Extract For Inhibiting Human Drug Transporters
#1872INFLAMMATORY CYTOKINE RELEASE INHIBITOR
#1873Compositions and methods for polymer-caged liposomes
#1874Method of skin treatment for rosacea using epidermal growth factor
#1875Liver protection compounds of the cyclohexenone type from
#1876Agent for Preventing/Ameliorating Life Style-Related Diseases Containing Turmeric Essential Oil Component
#1877Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions
#1878Ginger Fraction For Inhibiting Human Cyp Enzymes
#1879Therapeutic methods and compositions involving isoflavones
#1880Methods for bone treatment by modulating an arachidonic acid metabolic or signaling pathway
#1881Microemulsions of Cannabinoid Receptor Binding Compounds
#1882Propofol analogs, process for their preparation, and methods of use
#1883Anti-bacterial, anti-virus, and anti-fungus composition, its preparation and use
#1884Green Alga Extract with High Astaxanthin Content and Method of Producing the Same
#1885Formulation of active agent loaded activated PLGA nanoparticles for targeted cancer nano-therapeutics
#1886INFLAMMATORY CYTOKINE RELEASE INHIBITOR
#1887Protein Kinase Modulation by Hops and Acacia Products
#1888Composition to enhance the bioavailability of curcumin
#1889Use of long-chain alcohol derivatives for the treatment of alopecia areata
#1890Biodegradable cationic polymers
#1891Inhibitory or blocking agents of molecular generating and/or inducing functions
#1892Preparation for Treating Cancer
#1893Novel Interleukin-1 and Tumor Necrosis Factor-Alpha Modulators, Syntheses of Said Modulators and Their Enantiomers and Methods of Using Said Modulators
#1894Method of treatment of virus infections using shikonin compounds
#1895Compositions and Methods Comprising Zingiber Species
#1896Diagnosis and treatment of cancer related to human dormancy
#1897Solubilized CoQ-10 and carnitine
#1898Thiol reactive agents as a therapeutic modality
#1899Method for improving the shelf-life of hematoxylin staining solutions
#1900COMBINATION THERAPY FOR REDUCTION OF TOXICITY OF CHEMOTHERAPEUTIC AGENTS
#1901Liposomal curcumin for treatment of diseases
#1902COMPOUNDS WITH ANTI-ANDROGENIC ACTIVITY AND THE USE THEREOF
#1903Methods for reducing circulating glucose levels
#1904Synergistic Effects Of Docosahexaenoic Acid (DHA) And Carotenoid Absorption Of Cognitive Function
#1905Novel Interleukin-1 and Tumor Necrosis Factor-Alpha Modulators, Syntheses of Said Modulators and Their Enantiomers and Methods of Using Said Modulators
#1906LIPOSOMAL CURCUMIN FOR TREATMENT OF NEUROFIBROMATOSIS
#1907Reagents and methods to treat ocular diseases and infection
#1908METHODS FOR INHIBITING THE PRODUCTION OF TSST-1
#1909Pharmaceutical compositions useful in prevention and treatment of Beta-amyloid protein-induced disease
#1910INTRANASALLY ADMINISTERING CURCUMIN PRODRUGS TO THE BRAIN TO TREAT ALZHEIMER'S DISEASE
#1911Drug design for tubulin inhibitors, compositions, and methods of treatment thereof
#1912ANTIVIRAL COMPOSITIONS AND METHODS OF USE
#1913INTRANASALLY ADMINISTERING CURCUMIN TO THE BRAIN TO TREAT ALZHEIMER'S DISEASE
#1914Combination chemotherapy compositions and methods
#1915Compressible resilient granules and formulations prepared therefrom
#1916Process for preparing fenofibrate compositions
#1917Fenofibrate compositions
#1918COMPOSITION AND METHOD FOR TREATING PSORIASIS
#1919Isoalpha acid based protein kinase modulation cancer treatment
#1920Xanthohumol and tetrahydro-isoalpha acid based protein kinase modulation cancer treatment
#1921Analgesic combination of tramadol and meloxicam
#1922Medical stent provided with a combination of melatonin and paclitaxel
#1923COMPOSITION AND METHOD FOR FACILITATING THE HEALING OF NON-HEALING AND SLOW-HEALING WOUNDS AND ULCERATIONS
#1924Chemical compounds
#1925Protein kinase modulation by hops and acacia products
#1926Compositions and methods for alleviating joint pain and improving joint flexibility
#1927Sustained release compositions for the therapeutic management of pain, inflammation and inflammation-associated disorders and prophylactic/ therapeutic methods thereof
#1928Pharmaceutical Compositions Comprising Droxidopa
#1929Natural extract containing xanthohumol, and method for the production thereof products produced therefrom
#1930USE OF ETODOLAC TO TREAT HYPERPLASIA
#1931Orally administered compound for preventing neonatal hemorrhages, in a tardy form, caused by a K-vitamin dificiency
#1932Sustained release formulation of naltrexone
#1933Compounds having activity in increasing ion transport by mutant-CFTR and uses thereof
#1934Pharmaceutical compositions and methods for peptide treatment
#1935Methods and compositions for treatment of macular and retinal disease
#1936Highly absorbable coenzyme Q10 composition and method of producing same
#1937METHODS OF ADMINISTERING ANTI-INFLAMMATORY CYCLOOXYGENASE-2 SELECTIVE INHIBITORS
#1938Treatments for Congestive Heart Failure
#1939Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof
#1940Synergistic Anti-Inflammatory Pharmaceutical Compositions and Methods of Use
#1941Animal repellent composition and method
#1942Reduction of the Deleterious Effects of Tobacco Smoking
#1943Anthracenedione compounds
#1944Naphthalenedione compounds for treating inflammation related disorders and microbial infection
#1945Synergistic compositions useful as cytostatic, bacteriostatic and/or virostatic agents
#1946Nutritional system and methods for increasing longevity
#1947Methods of treating muscular wasting diseases using NF-κB activation inhibitors
#1948Antiviral methods and compositions
#1949Methods for the prevention and/or the treatment of glutamate cytotoxicity
#1950Methods for the prevention and/or the treatment of glutamate cytotoxicity
#1951Methods for the prevention and/or the treatment of glutamate cytotoxicity
#1952Compressible resilient granules and formulations prepared therefrom
#1953BLADDER CANCER TREATMENT AND METHODS
#1954Oligomeric ketone compounds
#1955Modulators of ion channel trpa1
#1956Composition and Method for Mitigating a Negative Effect of Alcohol Consumption
#1957Use Of Licochalcone A Or Of An Extract Of Licochalcone A From Radix Glycyrrhizae Inflatae Against Skin Aging
#1958Withacnistin compounds for treatment of cancer
#1959Analgesic combination of oxycodone and celecoxib
#1960Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases
#1961Process for producing fenofibrate tablets
#1962Non-Absorbent Articles Containing Additives for Inhibiting the Production of TSST-1
#1963Propofol analogs, process for their preparation, and methods of use
#1964Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
#1965BLADDER CANCER TREATMENT AND METHODS
#1966Compositions that treat or inhibit pathological conditions associated with inflammatory response
#1967Process for producing fenofibrate tablets
#1968Compositions for delivery of coenzyme Q10
#1969Complex Mixtures Exhibiting Selective Inhibition of Cyclooxygenase-2
#1970Treatment modalities for autoimmune diseases
#1971Pharmaceutical composition for treating and preventing cancer comprising cinnamoni cortex extract and zizyphi fructus extract
#1972Protein kinase modulation by hops and Acacia products
#1973Therapeutic formulation
#1974Composition to enhance the bioavailability of curcumin
#1975Method of Treating Cancer
#1976Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2
#1977Use of licochalcone A against rosacea
#1978Wound healing compound
#1979Apparatus and method of wart treatment
#1980Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision
#1981Antimalarial drug containing synergistic combination of curcumin and artemisinin
#1982LATENT REACTIVE BLOOD COMPATIBLE AGENTS
#1983Compositions for treatment of cancer and inflammation with curcumin and at least one nsaid
#1984Skin rejuvinating supplement
#1985LATENT REACTIVE BLOOD COMPATIBLE AGENTS
#1986Methods and compositions for stabilizing an antioxidant
#1987Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
#1988Inhibitory or blocking agents of molecular generating and/or inducing functions
#1989Therapeutic curcumin derivatives
#1990Composition for inhibition or prevention of bone density
#1991Coenzyme Q10-containing fine particle with excellent dispersibility
#1992Protein kinase modulation by hops and products
#1993Therapeutic compositions
#1994Formulations comprising fenofibrate and a statin, and related methods of treatment
#1995Hsp90 family protein inhibitors
#1996Ketones and reduced ketones as therapeutic agents for the treatment of bone conditions
#1997Benzoquinones of enhanced bioavailability
#1998Treatment modalities for autoimmune diseases
#1999Water-dispersible carotenoids, including analogs and derivatives
#2000Composition for improving the efficacy and reducing the side effects of omega 3 fatty acids, fish oils and cardiovascular and diabetic treatments
#2001Methods of administering anti-inflammatory cyclooxygenase-2 selective inhibitors
#2002STAT3 decoy oligonucleotides and uses therefor
#2003Active substance combination of licochalcone A and phenoxyethanol
#2004Therapeutic methods and compositions involving isoflavones
#2005Methods of treating hyperproliferative cell disorders
#2006Cancer treatment using curcumin derivatives
#2007Carotenoids, carotenoid analogs, or carotenoid derivatives for the treatment of proliferative disorders
#2008Compositions and methods for the treatment of allergic rhinitis
#2009Methods and compositions for augmenting cancer chemotherapeutic agents
#2010Skin care compositions containing idebenone
#2011Skin care compositions containing idebenone
#2012Synergistic effects of docosahexaenoic acid (DHA) and carotenoid absorption on macular pigmentation
#2013Use of chalcones for the treatment of viral disorders
#2014Carotenoids, carotenoid analogs, or carotenoid derivatives for the treatment of visual disabilities
#2015Biodegradable medical devices with enhanced mechanical strength and pharmacological functions
#2016Blockade of Pin1 prevents cytokine production by activated immune cells
#2017Topical composition containing essential oils
#2018Ketocarotenoids from
#2019Method and compounds for cancer treatment utilizing NFkB as a direct or ultimate target for small molecule inhibitors
#2020Biodegradable cationic polymers
#2021Interleukin-1 and tumor necrosis factor-α modulators, synthesis of said modulators and their enantiomers and methods of using said modulators
#2022Mitochrondrial permeability transition pore affinity labels and modulators
#2023Skin enrichment using CoQ10 as the delivery system
#2024Small molecule inhibitors of STAT3 and the uses thereof
#2025Anti-bacterial, anti-virus, and anti-fungus composition, its preparation and use
#2026Crystalline levosalbutamol sulphate and polymorphic forms thereof
#2027Antibacterial compounds and uses thereof
#2028Treatment of Human Multiple Myeloma by Curcumin
#2029Nutritional supplements for cardiovascular health
#2030COMPOSITION OF AND METHOD FOR PREPARING STABLE PARTICLES IN A FROZEN AQUEOUS MATRIX
#2031COMPOSITION OF AND METHOD FOR PREPARING STABLE PARTICLES IN A FROZEN AQUEOUS MATRIX
#2032Natural astaxanthin extract reduces dna oxidation
#2033Methods of identifying therapeutic targets for the treatment of vulvovaginal atrophy
#2034Gelled immunomodulating topical compositions and a method of treating warts and other human papilloma virus skin infections
#2035Synergistic Effects of Nuclear Transcription Factor NF-kB Inhibitors and Anti-Neoplastic Agents
#2036Colorectal cancer therapies
#2037Inhibitors of RecA activities for control of antibiotic-resistant bacterial pathogens
#2038Ubiquinone composition and a container for its convenient transport and storage
#2039Modulation of inflammation by hops fractions and derivatives
#2040Compositions and methods for the treatment of leukemia
#2041Method for treating depression and/or anxiety
#2042Combination chemotherapy compositions and methods
#2043Crystalline form of zoledronic acid
#2044Use of inhibitors of soluble epoxide hydrolase to synergize activity of COX and 5-LOX inhibitors
#2045Compositions that treat or inhibit pathological conditions associated with inflammatory response
#2046Formulation for increasing the deposition of dietary carotenoids in eggs
#2047Compositions comprising vitamin k for treating or preventing age-related stiffening of arteries
#2048Herbal supplement to support weight loss
#2049Novel nutraceutical compositions comprising epigallocatechin gallate
#2050Anti-cancer agents
#2051Prevention of Systemic Microbial Infection
#2052Method for treating and preventing male infertility
#2053IMPROVED COX-2 INHIBITORY COMPOSITIONS AND THERAPEUTIC REGIMEN
#2054Skin photoageing and actinic damage treatment
#2055Repair of dna mutagenic damage
#2056Methods for treatment of beta-amyloid protein-induced ocular disease
#2057Therapeutic composition
#2058Remedies
#2059Immune system enhancement and stimulation formulation
#2060Bioactive dispersible formulation
#2061Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment of prevention of gastric toxicity
#2062Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity
#2063Composition of biochemical compounds involved in bioenergy metabolism of cells and method of use
#2064Composition for improving blood fluidity
#2065Compositions useful to treat ocular neovascular diseases and macular degeneration
#2066Compositions and methods for pulmonary conditions
#2067Novel pharmacophore for the discovery and testing of na,k-atpase inhibitor compositions and methods for their use in treating cardiovascular diseases and conditions
#2068Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response
#2069Modulation of inflammation by hops fractions and derivatives
#2070Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response
#2071Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response
#2072Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response
#2073Modulation of inflammation by hops fractions and derivatives
#2074Modulation of inflammation by hops fractions and derivatives
#2075Anti-inflammatory formulations
#2076Controlled-Release of Cosmetic and Pharmaceutical Agents via Osmotic Nano-Diffusion from Zeolite Cage Complexes
#2077Coenzyme Q10 as antiapoptotic agent
#2078METHOD FOR TREATING SKIN DISORDERS WITH XANTHOPHYLLS
#2079Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism
#2080Dihydroxyphenyl compounds and glucoside compounds thereof
#2081Compositions for treating obesity and insulin resistance disorders
#2082Cancer chemotherapy
#2083Novel inhibitors of ubiquitin isopeptidases
#2084Butyrophenones and sigma-1 receptor antagonists protect against oxidative-stress
#2085Treatment of Stargardt's disease and other lipofuscin disorders with combined retinaldehyde inhibitor and zeaxanthin
#2086Methods and compositions for enhancing degradation of nuclear receptor transcription factors and uses thereof
#2087Treatment of muscle fatigue
#2088Method of using coenzyme Qto treat Huntington's disease
#2089Using high-density grapes to rejuvenate human skin
#2090Matrix metalloprotease (MMP) inhibitors and their application in cosmetic and pharmaceutical composition
#2091Cytochrome P450 2C9 inhibitors
#2092Liposomal curcumin for treatment of cancer
#2093Compositions comprising ubiquinones
#2094Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
#2095External skin preparations for suppressing sebum secretion
#2096Latent reactive blood compatible agents
#2097Herbal medicaments for the treatment of neurocerebrovascular disorders
#2098Dietary supplement formulation for controlling inflammation and cancer
#2099Ocular formulations with neuroprotectants to reduce Alzheimer and neurotoxic risks created by large zinc dosages
#2100Inhibition of anaerobic glucose metabolism and corresponding composition as a natural non-toxic approach to cancer treatment